Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDVO.L Regulatory News (DVO)

  • There is currently no data for DVO

Trading Update

17 Jan 2020 07:00

RNS Number : 0947A
Devro PLC
17 January 2020
 

For immediate release 17 January 2020

Devro plc

 

Trading update

 

Devro plc ("Devro" or the "Group"), one of the world's leading manufacturers of collagen products for the food industry, issues the following trading update for the year ended 31 December 2019.

 

Full year edible collagen volumes were flat, with the Group delivering overall volume growth of 1% in the second half ("H2"). Slightly lower than anticipated H2 volumes, less favourable country mix combined with a smaller than expected FX benefit due to the strengthening of sterling means we now expect to report underlying operating profit for the year in the range of £39 - £40 million1.

 

Devro continues to execute its growth plans as set out in its "3Cs strategy", defending and building upon its strong market positions in mature markets2 and targeting to increase its share in emerging markets3. After a slower start in the first half of 2019 overall volumes in emerging markets grew 13% in the second half and 7% for the full year. Whilst overall volumes in North America grew 7%, growth during Q4 was not as strong as expected, specifically impacted by a longer than anticipated Christmas shutdown at a key customer. Market conditions in Japan and Europe continued to be challenging as previously guided. In Europe, we saw weak market sentiment, with lower promotional activity due to higher pork prices and the impact of de-stocking by some of our distributor partners, which we expect to continue into H1 2020. As a result, overall sales in mature markets declined 3% in the year.

 

Cost saving initiatives continued to deliver well and we will achieve £7m savings in FY 2019. Leverage at the year-end improved following positive working capital movements and we expect to report covenant net debt / covenant EBITDA of less than 2x as at 31 December 2019.

 

Our proposed plans for the closure of the Bellshill site in Scotland remain on track.

 

In 2020 we expect to achieve strong volume growth in emerging markets. In our mature markets we expect good volume growth in the North American snacking market and, whilst we anticipate a continuation of the challenging market conditions in Europe (particularly in the first half of 2020), we expect overall Group volumes to be ahead of 2019.

 

Devro will announce its results for the year ended 31 December 2019 on 4 March 2020.

 

 

Contacts:

 

Devro plc

Rutger Helbing

Chief Executive Officer

Tel: 020 3865 7637

Jackie Callaway

Chief Financial Officer

 

 

FTI Consulting

Richard Mountain / Nick Hasell

 

Tel: 020 3727 1340

1 Unaudited

2 Devro mature markets include: North America, Continental EU, UK & Ireland, Japan, Australia & NZ

3 Devro emerging markets include: Latin America, Russia & East, Middle East & Africa, South East Asia, China

 

ENDS

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTSFIFUMESSEDF
Date   Source Headline
6th Oct 20157:00 amRNSCompletion of acquisition
6th Aug 20153:51 pmRNSDirector/PDMR Shareholding
5th Aug 20157:00 amRNSINTERIM RESULTS
27th Jul 20152:53 pmRNSListing Rule 9.6.14(R) Disclosure
10th Jul 20157:00 amRNSAcquisition
9th Jun 201511:43 amRNSHolding(s) in Company
1st Jun 20157:00 amRNSTotal Voting Rights
28th May 20152:44 pmRNSHolding(s) in Company
28th May 20152:41 pmRNSHolding(s) in Company
26th May 20158:16 amRNSBlock Listing Six Monthly Return
7th May 20155:10 pmRNSDirector/PDMR Shareholding
29th Apr 20154:15 pmRNSResult of AGM
29th Apr 20157:00 amRNSTrading Update
27th Mar 20157:00 amRNSChange of Auditor
27th Mar 20157:00 amRNS2014 Annual Report
26th Mar 20154:00 pmRNSDirector/PDMR Shareholding
5th Mar 20153:19 pmRNSDirector/PDMR Shareholding
3rd Mar 20152:34 pmRNSDirector Dealings
3rd Mar 20157:00 amRNSRESULTS FOR THE YEAR ENDED 31 DECEMBER 2014
3rd Dec 20144:19 pmRNSBlock Listing Six Monthly Return
21st Oct 201411:27 amRNSDirector/PDMR Shareholding
21st Oct 20147:00 amRNSInterim Management Statement
6th Oct 20141:39 pmRNSHolding(s) in Company
29th Aug 201411:23 amRNSTotal Voting Rights
7th Aug 20149:04 amRNSHolding(s) in Company
1st Aug 20142:38 pmRNSDirector/PDMR Shareholding
30th Jul 20147:00 amRNS2014 Interim Results
19th Jun 201410:03 amRNSHolding(s) in Company
10th Jun 20145:00 pmRNSDirector/PDMR Shareholding
30th May 201411:18 amRNSHolding(s) in Company
30th May 20147:00 amRNSTotal Voting Rights
29th May 201410:13 amRNSDirector/PDMR Shareholding
23rd May 20147:00 amRNSBlock Listing Six Monthly Return
16th May 201411:01 amRNSDirector/PDMR Shareholding
15th May 20149:00 amRNSConfirmation of Board Change
13th May 20145:16 pmRNSDirector/PDMR Shareholding
8th May 201411:49 amRNSHolding(s) in Company
7th May 20147:00 amRNSFurther Information on US Private Placement
1st May 20142:12 pmRNSDirector Dealings
30th Apr 20144:48 pmRNSResult of AGM
30th Apr 20148:27 amRNSTotal Voting Rights
30th Apr 20147:01 amRNSAppointment of Chairman
28th Apr 20147:00 amRNSInterim Management Statement
24th Apr 20144:43 pmRNSHolding(s) in Company
27th Mar 20147:00 amRNSAnnual Financial Report
21st Mar 201411:12 amRNSAdditional Listing
17th Mar 20142:54 pmRNSHolding(s) in Company
10th Mar 201410:54 amRNSHolding(s) in Company
10th Mar 201410:26 amRNSHolding(s) in Company
5th Mar 20144:14 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.